• Revenue from operations up 165% to $12.38 million
• Strong sales of Neurio and Moroka product ranges
• Net operating cash flow of ($1.136 million), down from ($0.013) million in Q2 FY25

Jatcorp Limited (ASX: JAT), an Australian health and wellness consumer goods company, has provided its quarterly activities and cash flow report for the quarter ending 31 December 2025 (Q2 FY26). Key highlights include:- Revenue from operations were $12.38 million, up 165% compared to $4.68 million in the prior corresponding quarter (Q2 FY25)- The strong sales in Q2 FY26 were driven by increased demand for the Neurio product range in Australia and Hong Kong as well as continued growth of the Moroka product range in China- Net operating cash flow was ($1.136 million), down from ($0.013) million in Q2 FY25- Continued to progress positive discussions with distribution partners across Southeast Asia- Showcased manufacturing capabilities and product portfolio at the China International Import Expo (CIIE) in Shanghai- ANMA facility in Melbourne onboarded two new OEM clients and completed a major production line upgrade- Entered into a manufacturing arrangement with BTNature, under which BTNature transitioned the production of a substantial portion of its existing products to ANMAJatcorp CEO, Sean Li, stated that the company is pleased with the sales of its key brands this quarter and that conditions continue to be positive for both Neurio and Moroka. The company is also investigating further distribution opportunities across Southeast Asia.